ICYMI: Methotrexate: shall we split up?
Methotrexate (MTX) is widely used in rheumatic diseases yet poses common tolerance issues, especially for the oral form; and bioavailability is known to be limited for doses over 15mg.
https://t.co/EQV2LeaaGB https://t.co/bD2zJbXETv
Links:
ICYMI: Methotrexate: shall we split up? | RheumNow
https://bit.ly/41u1yH5
Dec-18-2023


